Risk factors for ptld - Study guides, Class notes & Summaries

Looking for the best study guides, study notes and summaries about Risk factors for ptld? On this page you'll find 34 study documents about Risk factors for ptld.

Page 2 out of 34 results

Sort by

BMTCN questions well answered rated A+
  • BMTCN questions well answered rated A+

  • Exam (elaborations) • 7 pages • 2023
  • Available in package deal
  • BMTCN What type of transplants commonly have PTLD as a secondary malignancy? - correct answer Allo HSCT with T-cell depleted graft Therapies associated with therapy-related acute leukemia and MDS - correct answer alkylating agents (eg. Cytoxan, cisplatin, melphalan, busulfan, ifos) , radiation, topoisomerase II inhibitors (eg. doxorubicin, etoposide, mitoxantrone) Genetic predispositions that increase risk of primary and secondary cancers - correct answer neurofibromatosis type 1, Fanconi...
    (0)
  • $12.99
  • + learn more
BMTCN questions and answers graded A+2023/2024
  • BMTCN questions and answers graded A+2023/2024

  • Exam (elaborations) • 7 pages • 2023
  • Available in package deal
  • BMTCN What type of transplants commonly have PTLD as a secondary malignancy? - correct answer Allo HSCT with T-cell depleted graft Therapies associated with therapy-related acute leukemia and MDS - correct answer alkylating agents (eg. Cytoxan, cisplatin, melphalan, busulfan, ifos) , radiation, topoisomerase II inhibitors (eg. doxorubicin, etoposide, mitoxantrone) Genetic predispositions that increase risk of primary and secondary cancers - correct answer neurofibromatosis type 1, Fanconi...
    (0)
  • $12.99
  • + learn more
BMTCN Q&A
  • BMTCN Q&A

  • Exam (elaborations) • 6 pages • 2024
  • BMTCN What type of transplants commonly have PTLD as a secondary malignancy? - ANSWER-Allo HSCT with T-cell depleted graft Therapies associated with therapy-related acute leukemia and MDS - ANSWER-alkylating agents (eg. Cytoxan, cisplatin, melphalan, busulfan, ifos) , radiation, topoisomerase II inhibitors (eg. doxorubicin, etoposide, mitoxantrone) Genetic predispositions that increase risk of primary and secondary cancers - ANSWER-neurofibromatosis type 1, Fanconi anemia Risk factors fo...
    (0)
  • $7.99
  • + learn more
BMTCN Exam Questions and correct Solutions
  • BMTCN Exam Questions and correct Solutions

  • Exam (elaborations) • 8 pages • 2023
  • Available in package deal
  • BMTCN Exam Questions and correct Solutions What type of transplants commonly have PTLD as a secondary malignancy? Therapies associated with therapy-related acute leukemia and MDS Genetic predispositions that increase risk of primary and secondary cancers Risk factors for PTLD Risk factors for secondary solid tumors Treatment options for PTLD Treatment options for secondary MDS/acute leukemia QOL domains Altered sexual health in male HSCT survivors Altered sexual health i...
    (0)
  • $12.99
  • + learn more
BMTCN Exam Questions & Answers 2023/2024
  • BMTCN Exam Questions & Answers 2023/2024

  • Exam (elaborations) • 7 pages • 2023
  • BMTCN Exam Questions & Answers 2023/2024 What type of transplants commonly have PTLD as a secondary malignancy? - ANSWER-Allo HSCT with T-cell depleted graft Therapies associated with therapy-related acute leukemia and MDS - ANSWER-alkylating agents (eg. Cytoxan, cisplatin, melphalan, busulfan, ifos) , radiation, topoisomerase II inhibitors (eg. doxorubicin, etoposide, mitoxantrone) Genetic predispositions that increase risk of primary and secondary cancers - ANSWER-neurofibromatosis ...
    (0)
  • $8.49
  • + learn more
CCTC EXAM QUESTIONS WITH CORRECT ANSWERS 100% VERIFIED UPDATED 2024/2025 (100% Verified)
  • CCTC EXAM QUESTIONS WITH CORRECT ANSWERS 100% VERIFIED UPDATED 2024/2025 (100% Verified)

  • Exam (elaborations) • 8 pages • 2024
  • Available in package deal
  • CCTC EXAM QUESTIONS WITH CORRECT ANSWERS LATEST UPDATED 2024/2025 (100% Verified) CMV IgG (+) & IgM (-) - Answer Past CMV infection, not recent Blood Type O - Answer Universal Donor - Can receive subtype A2 Blood Type AB - Answer Universal Recipient Kidney Priority Listing Criteria - Answer 1) If candidate is prior living kidney donor 2) If there are 0 HLA-mismatches Common causes of HLA Antibody production - Answer 1) Transfusions 2) Pregnancy 3) Previous transplants Hep C Ab - Answer ...
    (0)
  • $15.49
  • + learn more
CCTC EXAM QUESTIONS WITH CORRECT ANSWERS LATEST UPDATED 2024/2025 (100% VERIFIED)
  • CCTC EXAM QUESTIONS WITH CORRECT ANSWERS LATEST UPDATED 2024/2025 (100% VERIFIED)

  • Exam (elaborations) • 8 pages • 2024
  • Available in package deal
  • CCTC EXAM QUESTIONS WITH CORRECT ANSWERS LATEST UPDATED 2024/2025 (100% VERIFIED) CMV IGG & IGM (-) - Answer Not previously CMV infected CMV IgG & IgM (+) - Answer Recent CMV infection CMV IgG (+) & IgM (-) - Answer Past CMV infection, not recent Blood Type O - Answer Universal Donor - Can receive subtype A2 Blood Type AB - Answer Universal Recipient Kidney Priority Listing Criteria - Answer 1) If candidate is prior living kidney donor 2) If there are 0 HLA-mismatches Common causes of HL...
    (0)
  • $13.99
  • + learn more
CCTC Exam Questions and Answers 100% Pass
  • CCTC Exam Questions and Answers 100% Pass

  • Exam (elaborations) • 7 pages • 2024
  • Available in package deal
  • CCTC Exam Questions and Answers 100% Pass CMV IGG & IGM (-) - Correct Answer ️️ -Not previously CMV infected CMV IgG & IgM (+) - Correct Answer ️️ -Recent CMV infection CMV IgG (+) & IgM (-) - Correct Answer ️️ -Past CMV infection, not recent Blood Type O - Correct Answer ️️ -Universal Donor - Can receive subtype A2 Blood Type AB - Correct Answer ️️ -Universal Recipient Kidney Priority Listing Criteria - Correct Answer ️️ -1) If candidate is prior living kidney don...
    (0)
  • $11.49
  • + learn more
BMTCN - Chapters 7-8 questions and answers graded A+ 2023/2024
  • BMTCN - Chapters 7-8 questions and answers graded A+ 2023/2024

  • Exam (elaborations) • 3 pages • 2023
  • Available in package deal
  • BMTCN - Chapters 7-8What has contributed to the increased number of HSCTs? - correct answer -Treatment of older recipients with reduced-intensity conditioning -Increased number of donors What are the 4 categories of second malignancies? - correct answer 1. Acute leukemia and MDS 2. Lymphoma, including post-transplant lymphoproliferative disorders (PTLDs) 3. Solid tumors 4. Skin cancers (carcinoma) PTLD is the most common second malignancy in the first year following which type of tran...
    (0)
  • $9.99
  • + learn more
CCTC EXAM QUESTIONS WITH CORRECT ANSWERS, LATEST UPDATED 2024/2025 (GRADED)
  • CCTC EXAM QUESTIONS WITH CORRECT ANSWERS, LATEST UPDATED 2024/2025 (GRADED)

  • Exam (elaborations) • 8 pages • 2024
  • CMV IGG & IGM (-) - Answer Not previously CMV infected CMV IgG & IgM (+) - Answer Recent CMV infection CMV IgG (+) & IgM (-) - Answer Past CMV infection, not recent Blood Type O - Answer Universal Donor - Can receive subtype A2 Blood Type AB - Answer Universal Recipient Kidney Priority Listing Criteria - Answer 1) If candidate is prior living kidney donor 2) If there are 0 HLA-mismatches Common causes of HLA Antibody production - Answer 1) Transfusions 2) Pregnancy 3) Previous transpla...
    (0)
  • $14.49
  • + learn more